Scandion Oncology A/S (OSTO:SCOL) Other Long Term Assets : kr3.95 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Scandion Oncology A/S Other Long Term Assets?

Scandion Oncology A/S's other long-term assets for the quarter that ended in Mar. 2024 was kr3.95 Mil.

Scandion Oncology A/S's quarterly other long-term assets declined from Sep. 2023 (kr9.12 Mil) to Dec. 2023 (kr0.37 Mil) but then increased from Dec. 2023 (kr0.37 Mil) to Mar. 2024 (kr3.95 Mil).

Scandion Oncology A/S's annual other long-term assets declined from Dec. 2021 (kr0.43 Mil) to Dec. 2022 (kr0.43 Mil) and declined from Dec. 2022 (kr0.43 Mil) to Dec. 2023 (kr0.37 Mil).

Scandion Oncology A/S Other Long Term Assets Historical Data

The historical data trend for Scandion Oncology A/S's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandion Oncology A/S Other Long Term Assets Chart

Scandion Oncology A/S Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

0.14

0.20

0.43

0.37

Scandion Oncology A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															4.38	8.44	9.12	0.37	3.95

Scandion Oncology A/S Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Scandion Oncology A/S (OSTO:SCOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandion Oncology A/S (OSTO:SCOL) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

8VY:Germany

Address

Fruebjergvej 3, Symbion, Copenhagen, DNK, 2100

Website

https://www.scandiononcology.com

Scandion Oncology A/S is a clinical-stage biotechnology company developing first-in-class medicines aimed at treating cancer that is resistant to current treatment options. Cancer Drug Resistance Company discovers and develops first-in-class medicines aimed at treating cancer that is resistant to current treatment options.

Scandion Oncology A/S (OSTO:SCOL) Headlines

No Headlines